Trial intelligence / Profile preview

Sex Steroid Hormones and Serotonin Transporter Binding

NCT01065220Phase 4Completed

Sponsor
Medical University of Vienna
Start
Feb 2010
Primary completion
Jan 2014
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 4 trial of estradiol, testosterone undecanoate in gender dysphoria (GD), sponsored by Medical University of Vienna. Started Feb 2010; status: completed.

02

Drugs

estradioltestosterone undecanoate
03

Conditions

gender dysphoria (GD)

Beyond the preview

Go deeper on NCT01065220.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01065220.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call